{"id":7321,"name":"Milltrust International","slug":"milltrust-international","website":"milltrust.com","hqGeo":null,"stageFocus":[],"sectorTags":[],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":null,"thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"52 North Health","companyUrl":null,"stage":"Early-stage; pre-seeded portfolio","sector":"Healthcare / Medtech","investmentYear":null,"description":"Develops diagnostic technology to quickly identify chemotherapy patients at risk of neutropenic sepsis.","amountUsd":null,"relevanceNote":null,"fundName":"Future Health Fund"},{"companyName":"Jiva.ai","companyUrl":null,"stage":"Early-stage; pre-seeded portfolio","sector":"Healthcare / AI","investmentYear":null,"description":"Uses a model-fusion approach to machine learning to build diagnostic solutions for human diseases.","amountUsd":null,"relevanceNote":null,"fundName":"Future Health Fund"},{"companyName":"Roslin Technologies","companyUrl":null,"stage":"Seed","sector":"Agrifood / Alternative protein","investmentYear":null,"description":"Provides animal stem-cell solutions for cultivated meat and sustainable food production.","amountUsd":null,"relevanceNote":null,"fundName":"Future Health Fund"},{"companyName":"Attomarker","companyUrl":null,"stage":"Early-stage; pre-seeded portfolio","sector":"Diagnostics / Medtech","investmentYear":null,"description":"Offers a COVID-19 triple antibody testing device for real-time immunity analysis.","amountUsd":null,"relevanceNote":null,"fundName":"Future Health Fund"},{"companyName":"Polymateria","companyUrl":null,"stage":"Series B","sector":"Climate / Materials / Biotech","investmentYear":null,"description":"Provides biodegradable solutions and additives for conventional plastic packaging to combat global plastic pollution.","amountUsd":null,"relevanceNote":null,"fundName":"British Innovation Fund II – Green Earth Ventures"},{"companyName":"IRNovate","companyUrl":null,"stage":"Early-stage","sector":"Healthcare / Medtech","investmentYear":null,"description":"Develops technology to improve liver biopsy procedures, enhancing safety and acceptance.","amountUsd":null,"relevanceNote":null,"fundName":"Future Health Fund"},{"companyName":"Eupnoos","companyUrl":null,"stage":"Early-stage","sector":"Healthcare / Respiratory diagnostics","investmentYear":null,"description":"Builds real-time breathing analysis technology to improve respiratory care and diagnostics.","amountUsd":null,"relevanceNote":null,"fundName":"Future Health Fund"},{"companyName":"Oncoshot","companyUrl":null,"stage":"Late seed / Series A","sector":"Healthcare / Oncology platform","investmentYear":null,"description":"Connects cancer patients and doctors to advanced treatment options and clinical trials to support precise cancer care pathways.","amountUsd":null,"relevanceNote":null,"fundName":"Asia Sustainable Impact Fund"},{"companyName":"Cody Genetics","companyUrl":null,"stage":"Early-stage","sector":"Agrifood / Genetics","investmentYear":null,"description":"Uses gene-editing technology to improve livestock farming, animal welfare, and resource efficiency.","amountUsd":null,"relevanceNote":null,"fundName":"Future Health Fund"},{"companyName":"BugEra","companyUrl":null,"stage":"Late seed / Series A","sector":"Climate / Agrifood / Bio-industrial","investmentYear":null,"description":"Develops modified black soldier fly strains to advance biofuel production and sustainable by-products.","amountUsd":null,"relevanceNote":null,"fundName":"Asia Sustainable Impact Fund"},{"companyName":"Shandi Global","companyUrl":null,"stage":"Late seed / Series A","sector":"FoodTech / Alternative protein","investmentYear":null,"description":"Produces plant-based food products and culinary innovations in the alternative protein sector.","amountUsd":null,"relevanceNote":null,"fundName":"Asia Sustainable Impact Fund"},{"companyName":"PragmatIC Semiconductors","companyUrl":null,"stage":"Not specified","sector":"Semiconductors / Deep tech","investmentYear":null,"description":"Develops ultra-low-cost flexible integrated circuits for embedding electronics into everyday objects.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Oxford Science Enterprises (OSE)","companyUrl":null,"stage":"Not specified","sector":"Investment platform / Deep tech","investmentYear":null,"description":"University-linked investment company commercialising Oxford University research in life sciences, health tech, and deep tech.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Viome","companyUrl":null,"stage":"Not specified","sector":"Digital health / AI","investmentYear":null,"description":"Health testing company using AI analysis of gut biology to provide personalised food and supplement recommendations.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Barinthus Biotherapeutics (previously Vaccitech)","companyUrl":null,"stage":"Reached NASDAQ listing in 2021","sector":"Biotech / Immunotherapy","investmentYear":null,"description":"Biotech firm developing vaccines and immunotherapies, and co-developer of the Oxford/AstraZeneca COVID-19 vaccine.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Totient","companyUrl":null,"stage":"Not specified","sector":"Biotech / AI","investmentYear":null,"description":"AI-driven drug discovery platform identifying human-derived antibodies from exceptional immune responses.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"AMLo Biosciences","companyUrl":null,"stage":"Not specified","sector":"Biotech / Diagnostics","investmentYear":null,"description":"Translates cancer biomarker research into prognostic and companion diagnostics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MyDoc","companyUrl":null,"stage":"Not specified","sector":"Digital health / Telemedicine","investmentYear":null,"description":"Asia-focused telemedicine platform connecting patients, doctors, pharmacies, labs, employers, and insurers.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CorePower","companyUrl":null,"stage":"Not specified","sector":"Energy / Nuclear tech","investmentYear":null,"description":"Develops scalable atomic power technology for ocean transport and heavy industry targeting zero-emission energy.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":4,"partners":[{"id":26142,"name":"Sean Ang","title":"Principal","seniority":null,"focusTags":["Early-stage investments","Science & Innovation","Food, Health, Planet"],"linkedinUrl":"https://www.linkedin.com/in/sean-ang-????","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":26140,"name":"Simon Hopkins","title":"General Partner","seniority":null,"focusTags":["Emerging Markets","Sustainability","Public & Private Markets","Venture Capital","One Health (Food, Health, Planet)"],"linkedinUrl":"https://www.linkedin.com/in/simon-hopkins-???","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":26141,"name":"Eric Anderson","title":"Head of Global Wealth Solutions & Global Emerging Markets, Milltrust International LLP","seniority":null,"focusTags":["Emerging Markets","Public Equity Funds","Wealth Solutions"],"linkedinUrl":"https://www.linkedin.com/in/eric-anderson-17b35a3","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":26143,"name":"Dr Bernard Ng","title":"Partner","seniority":null,"focusTags":["Healthcare / Medical Innovation","Clinical Affairs","Life Sciences"],"linkedinUrl":"https://www.linkedin.com/in/bernard-ng-????","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[],"featuredIn":[],"fundraisingResources":[{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":null}